Long-term growth Core Portfolio review
Hi everyone, I’m looking for some feedback and critiques on my Core portfolio architecture, which is designed for aggressive long-term growth with a 10-15+ year horizon, investing from Chile.
1. The ETF Core (Global Index Base)
This is the fixed allocation for my global base:
- 70% IWDA (iShares Core MSCI World - Developed Markets)
- 20% EIMI (iShares Core MSCI Emerging Markets IMI)
- 10% SMH (VanEck Semiconductor ETF)
Why these ETFs?
- Tax Optimization: For the bulk of my base (IWDA + EIMI), I deliberately chose Ireland-domiciled (UCITS) and accumulating versions. As a Chilean investor, US-domiciled funds subject us to a heavy 30% Withholding Tax (WHT) on dividends. Irish funds cut that WHT down to 15% due to tax treaties. Since they are accumulating, the funds automatically reinvest dividends internally, accelerating compound interest without triggering quarterly tax friction or cash drag.
- The SMH Thesis: I know semiconductors are a volatile and cyclical sector, but I kept this fixed 10% tilt because my thesis goes far beyond the current AI software hype cycle. I firmly believe in the long-term growth of advanced robotics (humanoids/industrial automation) and the commercial space economy. My goal is to buy the picks and shovels of the industry—no matter who builds the robot or the satellite, everyone will eventually need the cutting-edge hardware inside SMH (NVIDIA, TSMC, ASML, etc.).
2. The Satellites (Individual Stock Picks)
Outside of the ETFs, I invest directly in high-conviction stocks, specifically targeting technological supply**-chain bottlenecks:**
- AI & Hardware Bottlenecks: I hold positions in NBIS, MRVL (Marvell), and MU (Micron), and I am actively looking for small/medium caps that control critical processes or indispensable components in the AI infrastructure chain.
- Tactical Diversification: To avoid relying solely on the pure semiconductor/AI sector, I am expanding my stock picks into commercial space exploration via Rocket Lab and exploring opportunities in Health Tech.
My questions for the community:
- What are your general thoughts on the portfolio and the overall allocation?
- Does anything stand out as a red flag or a blind spot (especially regarding volatility or thesis overlap between EIMI, SMH, and my individual stock picks)?
*Note: I used an AI assistant to help refine the wording and keep it concise for Reddit, but the ideas and strategy are entirely my own.